Lataa...

Eculizumab in the treatment of Shiga toxin haemolytic uraemic syndrome

Haemolytic uraemic syndrome (HUS) remains a leading cause of paediatric acute kidney injury (AKI). Haemolytic uraemic syndrome is characterised by the triad of microangiopathic haemolytic anaemia, thrombocytopenia and AKI. In ~ 90% of cases, HUS is a consequence of infection with Shiga toxin-produci...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Pediatr Nephrol
Päätekijät: Walsh, Patrick R., Johnson, Sally
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer Berlin Heidelberg 2018
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6660499/
https://ncbi.nlm.nih.gov/pubmed/30058046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00467-018-4025-0
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!